ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

Clinical trial NCT04883918 · UNKNOWN

Trial details

NCT number: NCT04883918
Sponsor: ASC Therapeutics
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute-graft-versus-host Disease

Start date: 2023-12-01
Primary completion: 2026-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.